Hjertescanning med positronemissionstomografi - PET Klinisk anvendelse og forskningsmœssig betydning

Jens D. Hove, Morten Bøttcher, Klaus Fuglsang Kofoed, Hans Erik Bøtker, Christian Meyer, Henning Kelbœk, Torsten Toftegård Nielsen, Birger Hesse

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review

    Abstrakt

    Assessment of regional myocardial glucose metabolism and regional myocardial perfusion has become possible with positron emission tomography (PET). These parameters are of importance in distinguishing viable from fibrotic myocardium in patients with ischaemic heart disease. PET scanning appears to be the method of choice in these patients, which has led to an increased clinical application of PET as a method usable to select patients with severe heart disease before potential revascularisation. In the present review, PET technology is briefly described, together with an overview of the scientific evidence supporting the clinical application of cardiac PET. Finally, its applications in the fields of pathophysiology and pharmacology are briefly described.

    Bidragets oversatte titelCardiac scanning with positron emission tomography - PET Clinical and research aspect
    OriginalsprogDansk
    Sider (fra-til)5174-5179
    Antal sider6
    TidsskriftUgeskrift for laeger
    Vol/bind161
    Udgave nummer37
    StatusUdgivet - 13 sep. 1999

    Fingeraftryk

    Udforsk hvilke forskningsemner 'Hjertescanning med positronemissionstomografi - PET Klinisk anvendelse og forskningsmœssig betydning' indeholder.

    Citationsformater